• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[前列腺癌:融合基因的革命]

[Prostate cancer: the revolution of the fusion genes].

作者信息

Fernández-Serra A, Rubio-Briones J, García-Casado Z, Solsona E, López-Guerrero J A

机构信息

Laboratorio de Biología Molecular, Fundación Instituto Valenciano de Oncología, Valencia, España.

出版信息

Actas Urol Esp. 2011 Jul-Aug;35(7):420-8. doi: 10.1016/j.acuro.2010.11.019. Epub 2011 May 23.

DOI:10.1016/j.acuro.2010.11.019
PMID:21601955
Abstract

BACKGROUND

TMPRSS2-ETS fusion gene rearrangements constitute a very common and specific alteration in prostate cancer cells. These genetic alterations lead the overexpression of ETS genes which encode the E26 family of transcription factors involved in cell proliferation. Of this family, the ERG oncogene is overexpressed in almost 50% of prostate cancer cases.

EVIDENCE SYNTHESIS

TMPRSS2-ERG overexpresses ERG through an androgen-mediated response. Structurally, the rearrangement is due to interstitial deletion and to a lesser extent to reciprocal translocation and plays a key role in cellular metabolism. Almost all fusion gene transcripts produce a truncated ERG protein and the presence of a specific isoform of this gene suggests the clonality of the tumor; hence, metastasis shares the fusion gene status of their primary lesion. Although the prognostic implications of TMPRSS2-ERG have not been fully elucidated, they constitutes a field of great diagnostic potential and, therefore, the development of techniques to identify and to analyze the presence and characteristics of this gene in a non-invasive fashion deserves great interest in this area. Currently, there is evidence supporting the hypothesis that the presence of fusion gene differentiates two molecular groups within prostate cancer with a differential behaviour making the fusion gene a potential therapeutic target. In this regard, the use of anti-HDAC (trichostatin), antagonists of estrogen receptor alpha and abiraterone acetate have shown promising results.

CONCLUSIONS

This review describes the great potential offered by the investigation of fusion genes in PC and the need for further studies.

摘要

背景

TMPRSS2-ETS融合基因重排是前列腺癌细胞中一种非常常见且特异的改变。这些基因改变导致ETS基因的过表达,ETS基因编码参与细胞增殖的E26转录因子家族。在这个家族中,ERG癌基因在近50%的前列腺癌病例中过表达。

证据综合

TMPRSS2-ERG通过雄激素介导的反应使ERG过表达。在结构上,重排是由于间质性缺失,在较小程度上是由于相互易位,并且在细胞代谢中起关键作用。几乎所有的融合基因转录本都会产生截短的ERG蛋白,该基因特定异构体的存在提示肿瘤的克隆性;因此,转移灶与其原发灶具有相同的融合基因状态。尽管TMPRSS2-ERG的预后意义尚未完全阐明,但它们具有很大的诊断潜力,因此,开发以非侵入性方式识别和分析该基因的存在及其特征的技术在该领域备受关注。目前,有证据支持这样的假设,即融合基因的存在将前列腺癌分为两个分子亚组,它们具有不同的行为,这使得融合基因成为一个潜在的治疗靶点。在这方面,使用抗HDAC(曲古抑菌素)、雌激素受体α拮抗剂和醋酸阿比特龙已显示出有前景的结果。

结论

本综述描述了研究前列腺癌融合基因所提供的巨大潜力以及进一步研究的必要性。

相似文献

1
[Prostate cancer: the revolution of the fusion genes].[前列腺癌:融合基因的革命]
Actas Urol Esp. 2011 Jul-Aug;35(7):420-8. doi: 10.1016/j.acuro.2010.11.019. Epub 2011 May 23.
2
Clinical implications of TMPRSS2-ERG gene fusion expression in patients with prostate cancer treated with radical prostatectomy.在接受根治性前列腺切除术治疗的前列腺癌患者中,TMPRSS2-ERG 基因融合表达的临床意义。
J Urol. 2010 May;183(5):2054-61. doi: 10.1016/j.juro.2009.12.096. Epub 2010 Mar 19.
3
Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.50例前列腺癌中TMPRSS2-ERG和TMPRSS2-ETV1基因融合的分子遗传学分析。
Oncol Rep. 2007 May;17(5):1033-6.
4
Androgen regulation of ETS gene fusion transcripts in prostate cancer.雄激素对前列腺癌中ETS基因融合转录本的调控
Methods Mol Biol. 2011;776:335-48. doi: 10.1007/978-1-61779-243-4_19.
5
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.不同类型的染色体重排会在前列腺癌中产生致癌性ETS基因融合。
Nature. 2007 Aug 2;448(7153):595-9. doi: 10.1038/nature06024.
6
The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications.前列腺癌中常见的复发性跨膜蛋白酶丝氨酸2(TMPRSS2)-成红细胞增多症病毒E26转化序列(ETS)基因融合的发现:意义及临床应用
Adv Anat Pathol. 2009 May;16(3):145-53. doi: 10.1097/PAP.0b013e3181a12da7.
7
[Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer].[前列腺癌中TMPRSS2与ETS转录因子基因之间基因融合的频率及转录本变异分析]
Zhonghua Yi Xue Za Zhi. 2008 Mar 11;88(10):669-73.
8
Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer.前列腺特异性 TMPRSS2(exon 0)-ERG 融合转录物的过表达与前列腺癌的良好预后相关。
Clin Cancer Res. 2009 Oct 15;15(20):6398-403. doi: 10.1158/1078-0432.CCR-09-1176. Epub 2009 Oct 13.
9
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.家族性前列腺癌中TMPRSS2-ERG融合的全基因组连锁分析。
Cancer Res. 2009 Jan 15;69(2):640-6. doi: 10.1158/0008-5472.CAN-08-2008.
10
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.TMPRSS2:ERG基因融合与观察等待队列中致命性前列腺癌相关。
Oncogene. 2007 Jul 5;26(31):4596-9. doi: 10.1038/sj.onc.1210237. Epub 2007 Jan 22.

引用本文的文献

1
Individualized detection of TMPRSS2-ERG fusion status in prostate cancer: a rank-based qualitative transcriptome signature.个体化检测前列腺癌中 TMPRSS2-ERG 融合状态:基于排名的定性转录组特征。
World J Surg Oncol. 2024 Feb 9;22(1):49. doi: 10.1186/s12957-024-03314-8.
2
Association between TMPRSS2:ERG fusion gene and the prostate cancer: systematic review and meta-analysis.TMPRSS2:ERG融合基因与前列腺癌之间的关联:系统评价与荟萃分析。
Cent European J Urol. 2018;71(4):410-419. doi: 10.5173/ceju.2018.1752. Epub 2018 Nov 5.
3
Correlation between Fusion Protein and Androgen Receptor Expression by Immunohistochemistry in Prostate, Possible Role in Diagnosis and Therapy.
融合蛋白与雄激素受体在前列腺中的免疫组化表达相关性及其在诊断和治疗中的可能作用
J Cancer. 2017 Aug 5;8(13):2604-2613. doi: 10.7150/jca.16751. eCollection 2017.
4
Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.根据肿瘤TMPRSS2:ERG基因融合状态分析肥胖与前列腺癌风险
Am J Epidemiol. 2015 May 1;181(9):706-13. doi: 10.1093/aje/kwu344. Epub 2015 Apr 7.
5
Sarcosine as a potential prostate cancer biomarker--a review.肌氨酸作为一种潜在的前列腺癌生物标志物——综述。
Int J Mol Sci. 2013 Jul 4;14(7):13893-908. doi: 10.3390/ijms140713893.
6
Molecular characterization and clinical impact of TMPRSS2-ERG rearrangement on prostate cancer: comparison between FISH and RT-PCR.TMPRSS2-ERG 重排对前列腺癌的分子特征及临床影响:FISH 与 RT-PCR 比较。
Biomed Res Int. 2013;2013:465179. doi: 10.1155/2013/465179. Epub 2013 May 28.
7
miRNAs as biomarkers in prostate cancer.miRNAs 作为前列腺癌的生物标志物。
Clin Transl Oncol. 2012 Nov;14(11):803-11. doi: 10.1007/s12094-012-0877-0. Epub 2012 Jul 24.